Mednax trades as part of the health care providers industry and trades as part of the healthcare sector. The company CEO is Roger J. Medel. Mednax Inc is a provider of physician services that are newborn, anesthesia, maternal-fetal, teleradiology, pediatric cardiology and other pediatric subspecialty care. Anesthesiology and Neonatology and other pediatric subspecialties generate more income.
Previous Intraday Trading Performance:
The MD stock showed a previous change of 6.46% with an open at 25.68 and a close of 27.02. It reached an intraday high of 27.06 and a low of 25.54.
Business Wire: MEDNAX to Present at the Jefferies 2019 Global Healthcare Conference
Liquidity:
The stock has a market cap of $2.3b with 86.5m shares outstanding, of which the float is 83.4m shares. Trading volume reached 807,317 shares compared to its average volume of 1,088,223 shares. Based on the current average volume and close price, the trading liquidity is good.
Historical Trading Performance:
Over the last five trading days, Mednax shares returned 7.05% and in the past 30 trading days it returned 2.46%. Over three months, it changed -17.72%. In one year it has changed -41.00% and within that year its 52-week high was 48.77 and its 52-week low was 24.30. MD stock is 11.19% above its 52 Week Low.
Our calculations show a 200 day moving average of 36.47 and a 50 day moving average of 27.39. Currently MD stock is trading -25.92% below its 200 day moving average and may not be a good opportunity to buy as it may continue to trend down.
Business Wire: MEDNAX to Present at the Jefferies 2019 Global Healthcare Conference
Earnings:
The last annual fiscal EPS for the company was reported at 2.93 that ended on 31st of December 2018, which according to the previous close, that is a PE of 9.22. Based on 8 analyst estimates, the consensus EPS for the next quarter is 0.63. The TTM EPS is 3.51, which comes to a TTM PE of 7.70. Historically, the PE high was 27.10 and the PE low was 7.70. MD stock has set a new PE low record!
Below was the last reported quarterly diluted earnings per share:
| 1st | Qtr of 2019 | (Reported on 05/02/2019): | -2.82 |
|---|---|---|---|
| 4th | Qtr of 2018 | (Reported on 02/07/2019): | 0.68 |
| 3rd | Qtr of 2018 | (Reported on 11/01/2018): | 0.72 |
| 2nd | Qtr of 2018 | (Reported on 08/02/2018): | 0.85 |
| 1st | Qtr of 2018 | (Reported on 04/30/2018): | 0.68 |
Base on our calculations, the intrinsic value per share is 65.08, which means it is possibly undervalued and has a margin of safety of 58.48%.
Indicators to Watch:
Short-interest was 3,644,237, which was 4.21% of shares outstanding. The short-interest ratio or days-to-cover ratio was 3.15. This stock has some short interest, but it may be normal and no cause for concern if long the position.
The current calculated beta is 0.68.
SeekingAlpha: EMCOR Group, Inc. 2019 Q1 – Results – Earnings Call Slides
Fundamental Indicators:
Based on last reported financials, the company’s return on equity is -1.34%, return on assets is -0.68%, profit margin is -1.23%, price-to-sales is 0.63 and price-to-book is 0.79.
Company Scores:
All scores are out of six:
5 :Valuation Score
1 :Past Performance Score
2 :Financial Strength Score
0 :Future Growth Score
0 :Dividend Score
2 :Overall Score
